- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,890 | 17.07.24 22:00:11 | +0,450 | +0,36% | 125,800 | 125,890 | 125,470 | 125,440 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 101,150 | 17.07.24 22:00:09 | +2,200 | +2,22% | 101,050 | 101,150 | 97,660 | 98,950 |
